Cloud AI Expansion Dante Genomics already has a strategic AI collaboration with AWS to empower clinical genomics. This presents a sales opportunity to expand cloud-based data storage, scalable compute, healthcare-grade security and compliance, and managed services for deploying AI models across hospitals and research partners.

Rare Disease Growth The Rare Disease Health Package combines whole genome sequencing with telemedicine delivery. This is a pathway to scale into more clinics and payers, offering end-to-end WGS testing, variant interpretation, tele-genetic counseling, and seamless integration with the Dante Platform.

Proteomics Cross-sell SomaLogic’s proteomics collaboration can be extended by offering proteomics data generation and integration with Dante’s multiomics platform to improve biomarker discovery, patient stratification, and support clinical trial programs and pharma co-development.

Europe Expansion Active partnerships in Europe, including Italy, indicate a route to formalize hospital and payer collaborations, expand multiomics services, and localize offerings to align with European regulatory and reimbursement landscapes.

Platform Analytics Dante Platform’s AI-powered multiomics capabilities position the company to upsell enterprise licenses, integrated analytics dashboards, clinical decision support, and seamless data pipelines that accelerate adoption in hospitals, clinics and academic centers.